company background image
241 logo

Alibaba Health Information Technology SHSC:241 Stock Report

Last Price

HK$3.46

Market Cap

HK$55.6b

7D

-1.7%

1Y

-12.6%

Updated

23 Dec, 2024

Data

Company Financials +

Alibaba Health Information Technology Limited

SHSC:241 Stock Report

Market Cap: HK$55.6b

241 Stock Overview

An investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. More details

241 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance3/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Alibaba Health Information Technology Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Alibaba Health Information Technology
Historical stock prices
Current Share PriceHK$3.46
52 Week HighHK$6.30
52 Week LowHK$2.59
Beta1.09
1 Month Change-2.54%
3 Month Change2.98%
1 Year Change-12.63%
3 Year Change-47.18%
5 Year Change-61.68%
Change since IPO-74.02%

Recent News & Updates

Recent updates

Shareholder Returns

241HK Consumer RetailingHK Market
7D-1.7%-4.4%-0.5%
1Y-12.6%-27.4%19.9%

Return vs Industry: 241 exceeded the Hong Kong Consumer Retailing industry which returned -27.4% over the past year.

Return vs Market: 241 underperformed the Hong Kong Market which returned 19.9% over the past year.

Price Volatility

Is 241's price volatile compared to industry and market?
241 volatility
241 Average Weekly Movement13.7%
Consumer Retailing Industry Average Movement8.7%
Market Average Movement8.8%
10% most volatile stocks in HK Market18.6%
10% least volatile stocks in HK Market4.1%

Stable Share Price: 241's share price has been volatile over the past 3 months compared to the Hong Kong market.

Volatility Over Time: 241's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.

About the Company

FoundedEmployeesCEOWebsite
19981,422Difan Shenwww.alihealth.cn

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, health food, adult and family planning products, healthcare and skincare products, and various other health-related products. It also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, appointment-booking, vaccination, dental care, mental care, optometry, and nursing services, as well as traditional Chinese medicines.

Alibaba Health Information Technology Limited Fundamentals Summary

How do Alibaba Health Information Technology's earnings and revenue compare to its market cap?
241 fundamental statistics
Market capHK$55.64b
Earnings (TTM)HK$1.28b
Revenue (TTM)HK$30.17b

43.3x

P/E Ratio

1.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
241 income statement (TTM)
RevenueCN¥28.34b
Cost of RevenueCN¥21.78b
Gross ProfitCN¥6.56b
Other ExpensesCN¥5.35b
EarningsCN¥1.21b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.075
Gross Margin23.15%
Net Profit Margin4.26%
Debt/Equity Ratio0%

How did 241 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 03:07
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Alibaba Health Information Technology Limited is covered by 30 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xiaomeng ZhuangBofA Global Research
Shun Kei LawCCB International Securities Limited
Hazim BahariCFRA Equity Research